Related by context. All words. (Click for frequent words.) 79 amrubicin 76 TEMODAL 76 MabCampath 76 YONDELIS 75 Ambrisentan 75 Irinotecan 75 sunitinib malate 75 phase IIb clinical 75 HuMax CD4 74 Tarceva TM 74 Nexavar sorafenib 74 receptor tyrosine kinase inhibitor 74 Taxotere docetaxel 74 Ozarelix 74 Dasatinib 74 EOquin TM 74 Erbitux cetuximab 74 Aplidin 74 metastatic renal cell carcinoma 74 Fludara 74 Yondelis ® 73 Velcade bortezomib 73 sorafenib Nexavar 73 Pemetrexed 73 Nexavar ® 73 phase IIb trial 73 Temsirolimus 73 Torisel 73 liposomal formulation 73 Hycamtin ® 73 IL# PE#QQR 73 radiation sensitizer 73 Dapagliflozin 73 pegylated liposomal doxorubicin 73 HER2 positive metastatic breast 73 Degarelix 73 Mipomersen 73 vandetanib 73 Taxotere ® 73 Tavocept 73 Bevacizumab 73 OPAXIO 73 histone deacetylase HDAC inhibitor 73 Vandetanib 73 EOquin 73 docetaxel Taxotere R 73 Camptosar ® 73 Jevtana 73 bendamustine 73 AEG# 73 BAY #-# 72 Neulasta ® 72 ixabepilone 72 Gleevec Glivec 72 mTOR inhibitor 72 Aflibercept 72 elotuzumab 72 Annamycin 72 BRIM2 72 ularitide 72 OvaRex ® MAb 72 Pirfenidone 72 Peginterferon alfa 2b 72 TBC# 72 Azedra 72 Icatibant 72 Ixempra 72 Raptiva ® 72 ZACTIMA 72 iniparib 72 evaluating tivozanib 72 BRAF inhibitor 72 Treanda 72 Gleevec imatinib mesylate 72 Pivotal Phase III 72 oral ridaforolimus 72 FOLOTYN ® 72 Traficet EN 72 teriflunomide 72 JAK inhibitor 72 biologic therapy 72 MAGE A3 ASCI 72 Archexin 72 recurrent NSCLC 72 rilonacept 72 YERVOY 72 Onco TCS 72 Vectibix panitumumab 72 romiplostim 72 Civacir 72 Carfilzomib 72 sorafenib tablets 72 pomalidomide 72 thalidomide Thalomid 72 lumiliximab 72 pain palliation 72 Herceptin trastuzumab 72 Allovectin 7 71 forodesine 71 metaglidasen 71 cetuximab Erbitux 71 ThermoDox R 71 Cloretazine ® 71 Erlotinib 71 Loramyc R 71 aflibercept 71 temsirolimus 71 relapsed MM 71 Perifosine 71 mertansine 71 tanespimycin 71 Targretin 71 proteasome inhibitor 71 AQ4N 71 Hycamtin 71 goserelin 71 PDE4 inhibitor 71 Daclizumab 71 axitinib 71 HepaSphere 71 Bezielle 71 ZOLINZA 71 Tamibarotene 71 Xanafide 71 Proxinium TM 71 palonosetron 71 Vidaza azacitidine 71 CIMZIA ™ 71 Raptiva R 71 mRCC 71 Seliciclib 71 acyclovir Lauriad R 71 liposomal doxorubicin 71 Arixtra 71 YONDELIS R 71 immunotherapeutic agent 71 Fludara ® 71 mapatumumab 71 SNT MC# 71 cediranib 71 dacarbazine 71 trastuzumab DM1 71 regorafenib 71 GW# [003] 71 MGd 71 Pertuzumab 71 sunitinib Sutent 71 relapsed refractory multiple myeloma 71 Tarceva erlotinib 71 Alemtuzumab 71 Avastin bevacizumab 71 cinacalcet 71 Zarnestra 71 Kepivance 71 reslizumab 71 depsipeptide 71 relapsed multiple myeloma 71 VIDAZA 71 PROMACTA 71 refractory chronic lymphocytic 71 interferon gamma 1b 71 TREANDA 71 Myocet 71 dasatinib Sprycel ® 71 ACTEMRA TM 71 Clolar ® 71 Allovectin 7 ® 71 metastatic hormone refractory 71 CHOP chemotherapy 71 bevacizumab Avastin ® 71 glufosfamide 71 OMP designation 71 L BLP# 71 docetaxel Taxotere ® 71 PSMA ADC 70 pan HDAC inhibitor 70 Gefitinib 70 Nimotuzumab 70 Neulasta R 70 azacitidine 70 Alkeran 70 Bortezomib 70 Dacogen injection 70 6R BH4 70 UPLYSO 70 adalimumab Humira 70 Certican 70 BRIM3 70 dasatinib Sprycel 70 MYDICAR ® 70 anticancer compound 70 ONTAK 70 active comparator 70 Trastuzumab 70 eltrombopag 70 CIMZIA TM 70 generation purine nucleoside 70 Pazopanib 70 Pfizer Sutent 70 Rebif ® 70 trabectedin 70 ORENCIA ® 70 Revlimid lenalidomide 70 bevacizumab Avastin 70 oxaliplatin Eloxatin 70 Panzem R NCD 70 Azacitidine 70 CAELYX 70 Zolinza 70 HuMax EGFr 70 Targretin capsules 70 Epratuzumab 70 multiple myeloma MM 70 Vectibix 70 Troxatyl 70 TheraCIM 70 SCCHN 70 TRISENOX 70 standard chemotherapy regimen 70 ORENCIA R 70 alvespimycin 70 gemcitabine Gemzar 70 Phase 2a trial 70 indolent NHL 70 xanthine oxidase inhibitor 70 Docetaxel 70 panitumumab 70 Pegintron 70 phase IIa clinical 70 terlipressin 70 angiogenesis inhibitor 70 Genasense ® 70 Lubiprostone 70 metastatic CRC 70 Tanespimycin 70 Lenalidomide 70 Sanofi Aventis Taxotere 70 histamine dihydrochloride 70 atacicept 70 Glufosfamide 70 galiximab 70 cutaneous T cell 70 Phase Ib II 70 Aryplase 70 ONCASPAR 70 pitavastatin 70 Actemra tocilizumab 70 PHX# 70 Increlex R 70 cell lymphoma CTCL 70 Romiplostim 70 rNAPc2 70 EFAPROXYN 70 clofarabine 70 etanercept Enbrel 70 gefitinib Iressa 70 metastatic HRPC 70 Fibrin Pad 70 dirucotide MBP# 70 Urocidin 70 Trabectedin 70 R sorafenib tablets 70 Alocrest 70 IRESSA 70 multicenter Phase II 70 cetuximab Erbitux R 70 alkylating agent 70 TELCYTA 70 ELACYT 70 TYZEKA 70 carfilzomib 70 mycophenolate mofetil 70 AVONEX ® 70 ongoing Phase 1b 70 INTEGRILIN 70 pertuzumab 70 beta 1a 70 Evoltra 70 infusional 5-FU/LV 70 investigational antiplatelet agent 70 Taxotere R 70 Votrient 70 Phase IIIb clinical 70 Noxafil 70 neratinib 70 Gliadel Wafer 70 recurrent glioblastoma multiforme 70 Hsp# Inhibitor 70 TYKERB 70 RAPTIVA 69 TORISEL 69 methylnaltrexone 69 melphalan prednisone 69 SPRYCEL ® 69 FOLFIRI 69 rituximab Rituxan 69 Cimzia ® certolizumab pegol 69 Rituxan rituximab 69 Campath ® 69 icatibant 69 IMiDs ® compound 69 ASA# 69 Xelox 69 Cimzia certolizumab pegol 69 Phase Ib study 69 Leukine ® 69 Fludarabine 69 refractory acute myeloid 69 docetaxel chemotherapy 69 Sutent sunitinib 69 Elagolix 69 PEG SN# 69 Evoltra ® 69 Gemzar ® 69 DOXIL 69 PDX pralatrexate 69 BEXXAR 69 leukemia AML 69 BARACLUDE R 69 vascular disrupting agent 69 Azilect ® 69 bortezomib Velcade 69 refractory metastatic colorectal cancer 69 Zorbtive TM 69 Cloretazine 69 Omacetaxine 69 Gleevec resistant 69 gastrointestinal stromal tumors 69 refractory multiple myeloma 69 Doxil ® 69 romidepsin 69 mitogen activated ERK kinase 69 Phase III Clinical Trial 69 bazedoxifene 69 Tocilizumab 69 Roche Xeloda 69 CANCIDAS 69 IMA# 69 multicenter Phase III 69 RoACTEMRA 69 Argatroban 69 Candesartan 69 PEGylated anti 69 LAF# 69 phase III isavuconazole 69 EndoTAG TM -1 69 investigational humanized monoclonal antibody 69 Taxotere chemotherapy 69 CA4P 69 BR.# 69 alvimopan 69 zalutumumab 69 Navelbine ® 69 ospemifene 69 pegylated interferon alpha 69 CLARITY study 69 carboplatin paclitaxel 69 huC# DM4 69 COPAXONE ® 69 pediatric acute lymphoblastic 69 HGS# 69 Voreloxin 69 antiplatelet agent 69 plus dexamethasone 69 omacetaxine mepesuccinate 69 INCB# [002] 69 Advexin 69 phase IIb study 69 Camptosar 69 Gemcitabine 69 Soliris eculizumab 69 Phase Ib clinical 69 XGEVA 69 apaziquone 69 Bayer Nexavar 69 Alzhemed TM 69 cinacalcet HCl 69 Arranon 69 pegfilgrastim 69 Afatinib 69 clodronate 69 Factor VIIa 69 registrational trial 69 Vicinium TM 69 nilotinib 69 panitumumab Vectibix 69 midstage clinical 69 efaproxiral 69 ZADAXIN ® 69 Darusentan 69 phase Ib 69 TELINTRA 69 Tasigna nilotinib 69 Meets Primary Endpoint 69 Mimpara 69 tamibarotene 69 Gleevec imatinib 69 Betaferon R 69 Mycamine 69 Hepatocellular Carcinoma HCC 69 MGCD# [001] 69 Humira adalimumab 69 placebo controlled Phase 69 RANK Ligand inhibitor 69 vemurafenib 69 cutaneous T 69 Arimidex anastrozole 69 Plicera 69 Natalizumab 69 biliary tract cancer 69 thymalfasin 69 Firazyr 69 SIR Spheres 69 visilizumab 69 chemotherapeutic regimen 69 imatinib Gleevec ® 69 PEG INTRON 69 Virulizin R 69 rasagiline tablets 69 Plenaxis TM 69 efalizumab 69 Vidaza R 69 Increlex ® 69 Satraplatin 69 refractory cutaneous T 69 Clofarabine 69 FOLOTYN 69 CTAP# Capsules 69 estramustine 69 alefacept 69 lapatinib Tykerb 69 CoFactor 69 dose escalation Phase 69 Panitumumab 68 rufinamide 68 Phase #b/#a clinical 68 dirucotide 68 Onrigin 68 Xeloda ® 68 IV Busulfex 68 gastrointestinal stromal tumors GIST 68 metastatic malignant 68 Nilotinib 68 seliciclib CYC# 68 Advagraf 68 adecatumumab 68 Everolimus 68 LymphoStat B belimumab 68 Epirubicin 68 non squamous NSCLC 68 vorinostat 68 Enzyme Replacement Therapy 68 Ocrelizumab 68 PRT# 68 MOZOBIL 68 Mylotarg 68 Phenoptin 68 Genentech Rituxan 68 Teysuno 68 ALGRX 68 FTY# 68 decitabine 68 acetonide FA 68 Onconase 68 NEUPOGEN 68 Exemestane 68 abiraterone acetate 68 PD LID 68 DU #b 68 Silodosin 68 Celgene Revlimid 68 Folfox 68 rALLy clinical trial 68 CLL8 68 Peginterferon 68 Actimmune ® 68 ruxolitinib 68 ganetespib 68 stage IIIb IV 68 fosbretabulin 68 Orphan Drug status 68 chlorambucil 68 gemcitabine cisplatin 68 enzastaurin 68 Zemplar Capsules 68 Onalta 68 Telcyta 68 AVASTIN 68 tyrosine kinase inhibitor 68 Rituximab 68 Romidepsin 68 Sapacitabine 68 Marqibo TM 68 darapladib 68 Actemra 68 LEUKINE 68 ATL# [001] 68 Caelyx 68 CLL SLL 68 CYT# potent vascular disrupting 68 Solazed 68 BAL# [002] 68 Sym# 68 Blinatumomab 68 Cx# [002] 68 Leukine 68 Dacogen decitabine 68 virus HCV protease inhibitor 68 novel histone deacetylase 68 tocilizumab 68 Capecitabine 68 Cetrorelix 68 CCX# 68 paclitaxel Taxol ® 68 Luteinizing Hormone Releasing Hormone 68 Pivotal Phase 68 platinum refractory 68 Halaven 68 HQK 68 erlotinib Tarceva ® 68 dose cohort 68 posaconazole 68 RhuDex ® 68 IMC A# 68 PrevOnco 68 NeoRecormon 68 Alvesco R 68 AEGR 68 refractory Hodgkin lymphoma 68 Tolvaptan 68 plasma kallikrein inhibitor 68 Ranolazine 68 custirsen 68 relapsed ovarian cancer 68 Zavesca R 68 Randomized Phase 68 Corlux 68 dose cohorts 68 Febuxostat 68 AP# [003] 68 paclitaxel carboplatin 68 rFVIIa 68 SUTENT 68 LIALDA 68 OHR/AVR# 68 Apaziquone 68 dacarbazine chemotherapy 68 non metastatic osteosarcoma 68 RSR# 68 alfa 2a 68 somatostatin analogue 68 protease inhibitor PI 68 miconazole Lauriad ® 68 metastatic GIST 68 chemoradiotherapy 68 anticancer agent 68 volociximab 68 paclitaxel poliglumex 68 Pimavanserin 68 Zybrestat 68 Cleviprex TM clevidipine 68 Thalomid ® 68 Zemplar 68 PNP inhibitor 68 Bendamustine 68 PEG IFN 68 OZURDEX ® 68 daclizumab 68 INCB# [003] 68 FASLODEX 68 BCG refractory 68 Cetuximab Erbitux 68 INC# 68 BARACLUDE ® 68 Abiraterone 68 Folotyn 68 cilengitide 68 Nexavar tablets 68 phase IIb 68 MabThera Rituxan 68 sorafenib Nexavar ® 68 sodium glucose cotransporter 68 INCB# [001] 68 Proleukin 68 sargramostim 68 regadenoson 68 KNS # 68 micafungin 68 KRN# 68 Insegia 68 vinorelbine 68 docetaxel Taxotere 68 FOLFOX6 68 Asentar 68 Mitoxantrone 68 randomized controlled Phase 68 Pathway Inhibitor 68 sunitinib 68 Eltrombopag 68 ONGLYZA ™ 68 Doxil 68 CEQ# 68 Phase III Trial 68 CINTREDEKIN BESUDOTOX 68 PANVAC VF 68 capecitabine Xeloda 68 novel oral anticoagulant 68 Safinamide 68 topotecan 68 STRIDE PD 68 Serdolect ® 68 teduglutide 68 methylnaltrexone bromide 68 Laquinimod 68 IMiDs 68 luteinizing hormone releasing 68 bicalutamide 68 Neoadjuvant 68 concurrent chemoradiation 68 briakinumab 68 Saxagliptin 68 Tocosol Paclitaxel 68 satraplatin 68 Neupogen ® 68 Ophena TM 68 targeted radiotherapeutic 68 Platinol 68 nilotinib Tasigna 68 Maraviroc 68 T DM1 68 Dabigatran etexilate 68 vismodegib 68 Arzerra ofatumumab 68 metastatic colorectal 68 DPP4 inhibitor 68 oral deforolimus 67 Ceflatonin 67 Avonex interferon beta 1a 67 dose escalation clinical 67 pegylated interferons 67 erlotinib Tarceva 67 canakinumab 67 TAXUS Element Stent System 67 Diamyd ® 67 Boceprevir 67 dabigatran etexilate 67 CIMZIA TM certolizumab pegol 67 SinuNase TM 67 Cytoxan 67 Thrombin 67 VPRIV 67 Amigal 67 Pivotal Trial 67 TRISENOX ® 67 relapsing remitting MS RRMS 67 Arcalyst 67 Phase III randomized controlled 67 trastuzumab Herceptin R 67 Achieves Primary Endpoint 67 gastrointestinal stromal tumor GIST 67 Vicriviroc 67 Combination REOLYSIN R 67 OncoVEX GM CSF 67 Glatiramer Acetate 67 Pivotal Study 67 antibody MT# 67 PF # [001] 67 ZK EPO 67 Valsartan 67 metastatic castrate resistant 67 DXL# 67 small molecule Hedgehog 67 angiotensin II receptor blocker 67 Zevalin R Ibritumomab 67 VNP#M 67 ACZ# 67 Decitabine 67 Taxol paclitaxel 67 antibody MAb 67 subcutaneous formulation 67 REPLAGAL 67 plus gemcitabine 67 Levoleucovorin 67 LIVALO 67 BrachySil TM 67 GRN# 67 Androxal TM 67 Oncaspar 67 Cloretazine R VNP#M 67 Panzem R 67 Olmesartan 67 lupus nephritis 67 elacytarabine 67 selective modulator 67 HGS ETR1 67 Femara letrozole 67 R bendamustine hydrochloride 67 Ventavis 67 nonsmall cell lung cancer 67 novel VDA molecule 67 PEGylated Fab fragment 67 everolimus eluting stent 67 ® lenalidomide 67 irbesartan 67 VAPRISOL 67 adenosine injection 67 Eribulin 67 valopicitabine 67 talabostat 67 SCH # 67 Topotecan 67 SCIg 67 Aliskiren 67 double blinded placebo 67 Granulocyte Colony Stimulating Factor 67 Cloretazine R 67 drug eluting stent DES 67 microtubule inhibitor 67 Octreotide 67 Golimumab 67 stage IIIB 67 Octreolin 67 Ceflatonin R 67 LEP ETU 67 RG# [001] 67 NOXAFIL 67 gemcitabine carboplatin 67 multicenter randomized Phase 67 ritonavir boosted 67 malignant ascites 67 NXL# 67 PegIntron 67 Phase IIb clinical trials 67 HuMax CD# 67 GV# [001] 67 Specifid 67 vosaroxin 67 randomized Phase IIb 67 recurrent GBM 67 ximelagatran 67 baminercept 67 Iloperidone 67 herpetic keratitis 67 Deforolimus 67 riociguat 67 Nexavar sorafenib tablets 67 immunomodulatory therapy 67 AGGRASTAT ® 67 LUCENTIS 67 THALOMID 67 brivaracetam 67 Loramyc 67 APPRAISE 67 Combidex 67 Phase 2b trial 67 Reverset 67 Personalized Immunotherapy 67 AZILECT R 67 Vidofludimus 67 advanced metastatic renal 67 Chemophase 67 PREOS R 67 PEGINTRON TM 67 Fulvestrant 67 lexidronam injection 67 Vernakalant 67 Tasimelteon 67 IMiDs R 67 cetuximab Erbitux ® 67 GAMMAGARD 67 Maribavir 67 vinca alkaloid 67 Phase 2b Clinical Trial 67 Somatuline Depot 67 crizotinib PF # 67 EDEMA3 67 gemcitabine chemotherapy 67 LUX Lung 67 Cimzia TM 67 IgG1 monoclonal antibody 67 low dose cytarabine 67 Clevudine 67 lanthanum carbonate 67 mitoxantrone plus 67 ozarelix 67 RSD# iv 67 Eloxatin R 67 photoprotective drug 67 Vascular Wrap TM 67 phase IIIb 67 HGS ETR2 67 mCRC patients 67 SUTENT ® 67 selective androgen receptor modulator 67 sorafenib 67 cangrelor 67 calcineurin inhibitor 67 glatiramer acetate 67 Pralatrexate 67 placebo controlled Phase III 67 Gemzar gemcitabine 67 Ofatumumab 67 PROVENGE ® 67 lenalidomide Revlimid R 67 BCR ABL inhibitors 67 Patients Treated With 67 Filgrastim 67 corticosteroid dexamethasone 67 Betaseron ® 67 LHRH antagonist 67 HRPC 67 tesmilifene 67 nucleoside analog 67 Eloxatin ® 67 Bosutinib 67 VELCADE melphalan 67 Eluting Coronary Stent System 67 MyVax R 67 azacytidine 67 oropharyngeal candidiasis 67 veltuzumab 67 CD# antibody [001] 67 interferon beta 1b 67 sapacitabine 67 oral prodrug 67 trastuzumab DM1 T DM1 67 orally administered inhibitor 67 tafamidis 67 zileuton 67 idraparinux 67 XIENCE V Everolimus Eluting 67 ARCOXIA 67 ancrod 67 Orphan Drug designations 67 Engerix B 67 Interferon alfa 67 5 Fluorouracil 67 Orphan Drug designation 67 Azedra TM 67 albinterferon alfa 2b 67 sapacitabine CYC# 67 bendamustine HCl 67 TNF Tumor Necrosis Factor 67 HuLuc# 67 UVIDEM 67 relapsing multiple sclerosis 67 COPAXONE R 67 APTIVUS 67 BCR ABL inhibitor 67 Neurodex 67 orally bioavailable 67 Gattex 67 Evoltra TM 67 tigecycline 67 Tyrima 67 PrevOnco ™ 67 monoclonal antibody conjugated 67 eniluracil 67 olaparib 67 ZEVALIN 67 Phase 2b study 67 FOLFOX4 67 5-FU/LV 67 motesanib diphosphate 67 Promacta 67 Preotact R 67 lintuzumab 67 perifosine 67 Paraplatin 67 Iluvien ® 67 subcutaneously administered 67 REYATAZ R 67 Rivaroxaban 67 Hormone Refractory Prostate Cancer 67 GSK# [001] 67 Ranibizumab 67 generation Hsp# inhibitor 67 MEK inhibitor 67 relapsing remitting multiple sclerosis 67 taliglucerase alfa 67 ADP receptor antagonist 67 Initiate Phase 67 brentuximab vedotin SGN 67 demonstrated antitumor activity 67 EGS# 67 TYGACIL 67 placebo controlled clinical 67 paclitaxel Taxol R 67 INSPIRE Trial Phase III 67 Metastatic Melanoma 67 Novantrone 67 KRAS mutations occur 67 Removab 67 Tacrolimus 67 IV acetaminophen 66 SERMs 66 ACOMPLIA R 66 bortezomib Velcade R 66 Clolar 66 ThermoDox ® 66 Sanvar R 66 Metastatic Colorectal Cancer 66 multi kinase inhibitor 66 TH# [003] 66 sipuleucel T 66 Marqibo 66 Fibrillex TM 66 Phase Ib 66 Intravenous CP 66 Bevacizumab Avastin 66 CONBRIZA 66 ZEVALIN ® 66 silodosin 66 plus prednisone 66 albiglutide 66 TREDAPTIVE 66 Elitek 66 APTIVUS R 66 Telbivudine 66 budesonide foam 66 Ecallantide 66 ELOXATIN 66 HSP# inhibitor 66 Phase IIa trial 66 eplerenone 66 Vaprisol 66 Betaferon ® 66 deforolimus 66 Aptivus ® 66 ARCALYST ® rilonacept 66 R roscovitine 66 Talabostat 66 Sorafenib 66 tolevamer 66 histone deacetylase inhibitor 66 PI3K/Akt pathway inhibitor 66 cabazitaxel 66 superficial bladder cancer 66 lintuzumab SGN 66 Aloxi injection 66 #D#C# 66 EndoTAG 66 Diabetic Macular Edema 66 MIRCERA 66 monotherapy 66 Phase 2b clinical 66 Remicade infliximab 66 vapreotide acetate 66 MYLOTARG 66 MOVIPREP R 66 comparator arm 66 Modrenal R 66 GVAX 66 selective estrogen receptor modulator 66 oral Hycamtin 66 Cipralex ® 66 Oxaliplatin 66 Eli Lilly Gemzar 66 Zactima 66 cathepsin K inhibitor 66 Besivance 66 PLK1 SNALP 66 PROSTVAC TM 66 SAR# [004] 66 SUCCEED trial 66 Virulizin ® 66 ocular formulation 66 huN# DM1 66 EGFR TKI 66 R lenalidomide 66 Etoposide 66 oxypurinol 66 platelet inhibitor 66 factor Xa inhibitor 66 RELOVAIR ™ 66 metastatic RCC 66 Theratope 66 Eculizumab 66 REVLIMID R 66 Tesmilifene 66 eculizumab 66 HCV SPRINT 66 sitaxsentan 66 Cladribine 66 IV NSCLC 66 desvenlafaxine succinate 66 biologic DMARD 66 oral antidiabetic 66 IRX 2 66 levosimendan 66 BrachySil 66 Losartan 66 Vimpat R 66 multicenter clinical 66 Sudhir Agrawal D.Phil 66 EGFR expressing mCRC 66 paclitaxel Taxol 66 Phase IIIb study 66 fluoropyrimidine